Epidemiology  ||| S:0 E:13 ||| NNP
of  ||| S:13 E:16 ||| IN
HIV  ||| S:16 E:20 ||| NNP
among  ||| S:20 E:26 ||| IN
female  ||| S:26 E:33 ||| JJ
sex  ||| S:33 E:37 ||| NN
workers ||| S:37 E:44 ||| NNS
,  ||| S:44 E:46 ||| ,
their  ||| S:46 E:52 ||| PRP$
clients ||| S:52 E:59 ||| NNS
,  ||| S:59 E:61 ||| ,
men  ||| S:61 E:65 ||| NNS
who  ||| S:65 E:69 ||| WP
have  ||| S:69 E:74 ||| VBP
sex  ||| S:74 E:78 ||| NN
with  ||| S:78 E:83 ||| IN
men  ||| S:83 E:87 ||| NNS
and  ||| S:87 E:91 ||| CC
people  ||| S:91 E:98 ||| NNS
who  ||| S:98 E:102 ||| WP
inject  ||| S:102 E:109 ||| VBP
drugs  ||| S:109 E:115 ||| NNS
in  ||| S:115 E:118 ||| IN
West  ||| S:118 E:123 ||| NNP
and  ||| S:123 E:127 ||| CC
Central  ||| S:127 E:135 ||| NNP
Africa  ||| S:135 E:142 ||| NNP
The  ||| S:142 E:146 ||| NNP
West  ||| S:146 E:151 ||| NNP
and  ||| S:151 E:155 ||| CC
Central  ||| S:155 E:163 ||| NNP
Africa  ||| S:163 E:170 ||| NNP
( ||| S:170 E:171 ||| -LRB-
WCA ||| S:171 E:174 ||| NNP
)  ||| S:174 E:176 ||| -RRB-
sub-region  ||| S:176 E:187 ||| NNP
is  ||| S:187 E:190 ||| VBZ
the  ||| S:190 E:194 ||| DT
most  ||| S:194 E:199 ||| RBS
populous  ||| S:199 E:208 ||| JJ
region  ||| S:208 E:215 ||| NN
of  ||| S:215 E:218 ||| IN
sub-Saharan  ||| S:218 E:230 ||| NNP
Africa  ||| S:230 E:237 ||| NNP
( ||| S:237 E:238 ||| -LRB-
SSA ||| S:238 E:241 ||| NNP
) ||| S:241 E:242 ||| -RRB-
,  ||| S:242 E:244 ||| ,
with  ||| S:244 E:249 ||| IN
an  ||| S:249 E:252 ||| DT
estimated  ||| S:252 E:262 ||| JJ
population  ||| S:262 E:273 ||| NN
of  ||| S:273 E:276 ||| IN
356  ||| S:276 E:280 ||| CD
million  ||| S:280 E:288 ||| CD
living  ||| S:288 E:295 ||| NN
in  ||| S:295 E:298 ||| IN
24  ||| S:298 E:301 ||| CD
countries ||| S:301 E:310 ||| NNS
.  ||| S:310 E:312 ||| .
The  ||| S:312 E:316 ||| DT
HIV  ||| S:316 E:320 ||| NNP
epidemic  ||| S:320 E:329 ||| NN
in  ||| S:329 E:332 ||| IN
WCA  ||| S:332 E:336 ||| NNP
appears  ||| S:336 E:344 ||| VBZ
to  ||| S:344 E:347 ||| TO
have  ||| S:347 E:352 ||| VB
distinct  ||| S:352 E:361 ||| JJ
dynamics  ||| S:361 E:370 ||| NNS
compared  ||| S:370 E:379 ||| VBN
to  ||| S:379 E:382 ||| TO
the  ||| S:382 E:386 ||| DT
rest  ||| S:386 E:391 ||| NN
of  ||| S:391 E:394 ||| IN
SSA ||| S:394 E:397 ||| NNP
,  ||| S:397 E:399 ||| ,
being  ||| S:399 E:405 ||| VBG
more  ||| S:405 E:410 ||| RBR
concentrated  ||| S:410 E:423 ||| VBN
among  ||| S:423 E:429 ||| IN
key  ||| S:429 E:433 ||| JJ
populations  ||| S:433 E:445 ||| NNS
such  ||| S:445 E:450 ||| JJ
as  ||| S:450 E:453 ||| IN
female  ||| S:453 E:460 ||| JJ
sex  ||| S:460 E:464 ||| NN
workers  ||| S:464 E:472 ||| NNS
( ||| S:472 E:473 ||| -LRB-
FSWs ||| S:473 E:477 ||| NNP
) ||| S:477 E:478 ||| -RRB-
,  ||| S:478 E:480 ||| ,
men  ||| S:480 E:484 ||| NNS
who  ||| S:484 E:488 ||| WP
have  ||| S:488 E:493 ||| VBP
sex  ||| S:493 E:497 ||| NN
with  ||| S:497 E:502 ||| IN
men  ||| S:502 E:506 ||| NNS
( ||| S:506 E:507 ||| -LRB-
MSM ||| S:507 E:510 ||| NNP
) ||| S:510 E:511 ||| -RRB-
,  ||| S:511 E:513 ||| ,
people  ||| S:513 E:520 ||| NNS
who  ||| S:520 E:524 ||| WP
inject  ||| S:524 E:531 ||| VBP
drugs  ||| S:531 E:537 ||| NNS
( ||| S:537 E:538 ||| -LRB-
PWID ||| S:538 E:542 ||| NNP
)  ||| S:542 E:544 ||| -RRB-
and  ||| S:544 E:548 ||| CC
clients  ||| S:548 E:556 ||| NNS
of  ||| S:556 E:559 ||| IN
FSWs ||| S:559 E:563 ||| JJ
.  ||| S:563 E:565 ||| .
To  ||| S:565 E:568 ||| TO
explore  ||| S:568 E:576 ||| VB
the  ||| S:576 E:580 ||| DT
epidemiology  ||| S:580 E:593 ||| NN
of  ||| S:593 E:596 ||| IN
HIV  ||| S:596 E:600 ||| NNP
in  ||| S:600 E:603 ||| IN
the  ||| S:603 E:607 ||| DT
region ||| S:607 E:613 ||| NN
,  ||| S:613 E:615 ||| ,
a  ||| S:615 E:617 ||| DT
systematic  ||| S:617 E:628 ||| JJ
review  ||| S:628 E:635 ||| NN
of  ||| S:635 E:638 ||| IN
HIV  ||| S:638 E:642 ||| NNP
literature  ||| S:642 E:653 ||| NN
among  ||| S:653 E:659 ||| IN
key  ||| S:659 E:663 ||| JJ
populations  ||| S:663 E:675 ||| NNS
in  ||| S:675 E:678 ||| IN
WCA  ||| S:678 E:682 ||| NNP
was  ||| S:682 E:686 ||| VBD
conducted  ||| S:686 E:696 ||| VBN
since  ||| S:696 E:702 ||| IN
the  ||| S:702 E:706 ||| DT
onset  ||| S:706 E:712 ||| NN
of  ||| S:712 E:715 ||| IN
the  ||| S:715 E:719 ||| DT
HIV  ||| S:719 E:723 ||| NNP
epidemic ||| S:723 E:731 ||| NN
.  ||| S:731 E:733 ||| .
We  ||| S:733 E:736 ||| PRP
searched  ||| S:736 E:745 ||| VBD
the  ||| S:745 E:749 ||| DT
databases  ||| S:749 E:759 ||| JJ
PubMed ||| S:759 E:765 ||| NN
,  ||| S:765 E:767 ||| ,
CINAHL  ||| S:767 E:774 ||| NNP
and  ||| S:774 E:778 ||| CC
others  ||| S:778 E:785 ||| NNS
for  ||| S:785 E:789 ||| IN
peer-reviewed  ||| S:789 E:803 ||| JJ
articles  ||| S:803 E:812 ||| NNS
regarding  ||| S:812 E:822 ||| VBG
FSWs ||| S:822 E:826 ||| JJ
,  ||| S:826 E:828 ||| ,
MSM  ||| S:828 E:832 ||| NNP
and  ||| S:832 E:836 ||| CC
PWID  ||| S:836 E:841 ||| NNP
in  ||| S:841 E:844 ||| IN
24  ||| S:844 E:847 ||| CD
countries  ||| S:847 E:857 ||| NNS
with  ||| S:857 E:862 ||| IN
no  ||| S:862 E:865 ||| DT
date  ||| S:865 E:870 ||| NN
restriction ||| S:870 E:881 ||| NN
.  ||| S:881 E:883 ||| .
Inclusion  ||| S:883 E:893 ||| JJ
criteria  ||| S:893 E:902 ||| NNS
were  ||| S:902 E:907 ||| VBD
sensitive  ||| S:907 E:917 ||| JJ
and  ||| S:917 E:921 ||| CC
focused  ||| S:921 E:929 ||| VBN
on  ||| S:929 E:932 ||| IN
inclusion  ||| S:932 E:942 ||| NN
of  ||| S:942 E:945 ||| IN
any  ||| S:945 E:949 ||| DT
HIV  ||| S:949 E:953 ||| NNP
prevalence  ||| S:953 E:964 ||| NN
data  ||| S:964 E:969 ||| NNS
among  ||| S:969 E:975 ||| IN
key  ||| S:975 E:979 ||| JJ
populations ||| S:979 E:990 ||| NNS
.  ||| S:990 E:992 ||| .
HIV  ||| S:992 E:996 ||| NNP
prevalence  ||| S:996 E:1007 ||| NN
was  ||| S:1007 E:1011 ||| VBD
pooled ||| S:1011 E:1017 ||| VBN
,  ||| S:1017 E:1019 ||| ,
and  ||| S:1019 E:1023 ||| CC
in  ||| S:1023 E:1026 ||| IN
each  ||| S:1026 E:1031 ||| DT
country  ||| S:1031 E:1039 ||| NN
key  ||| S:1039 E:1043 ||| JJ
themes  ||| S:1043 E:1050 ||| NNS
were  ||| S:1050 E:1055 ||| VBD
extracted  ||| S:1055 E:1065 ||| VBN
from  ||| S:1065 E:1070 ||| IN
the  ||| S:1070 E:1074 ||| DT
literature ||| S:1074 E:1084 ||| NN
.  ||| S:1084 E:1086 ||| .
The  ||| S:1086 E:1090 ||| DT
search  ||| S:1090 E:1097 ||| NN
generated  ||| S:1097 E:1107 ||| VBD
885  ||| S:1107 E:1111 ||| CD
titles ||| S:1111 E:1117 ||| NNS
,  ||| S:1117 E:1119 ||| ,
214  ||| S:1119 E:1123 ||| CD
abstracts  ||| S:1123 E:1133 ||| NNS
and  ||| S:1133 E:1137 ||| CC
122  ||| S:1137 E:1141 ||| CD
full  ||| S:1141 E:1146 ||| JJ
articles ||| S:1146 E:1154 ||| NNS
,  ||| S:1154 E:1156 ||| ,
of  ||| S:1156 E:1159 ||| IN
which  ||| S:1159 E:1165 ||| WDT
76  ||| S:1165 E:1168 ||| CD
met  ||| S:1168 E:1172 ||| VBN
inclusion  ||| S:1172 E:1182 ||| NN
and  ||| S:1182 E:1186 ||| CC
exclusion  ||| S:1186 E:1196 ||| NN
criteria  ||| S:1196 E:1205 ||| NNS
providing  ||| S:1205 E:1215 ||| VBG
HIV  ||| S:1215 E:1219 ||| NNP
prevalence  ||| S:1219 E:1230 ||| NN
data ||| S:1230 E:1234 ||| NNS
.  ||| S:1234 E:1236 ||| .
There  ||| S:1236 E:1242 ||| EX
were  ||| S:1242 E:1247 ||| VBD
60  ||| S:1247 E:1250 ||| CD
articles  ||| S:1250 E:1259 ||| NNS
characterizing  ||| S:1259 E:1274 ||| VBG
the  ||| S:1274 E:1278 ||| DT
burden  ||| S:1278 E:1285 ||| NN
of  ||| S:1285 E:1288 ||| IN
disease  ||| S:1288 E:1296 ||| NN
among  ||| S:1296 E:1302 ||| IN
FSWs ||| S:1302 E:1306 ||| NNP
,  ||| S:1306 E:1308 ||| ,
eight  ||| S:1308 E:1314 ||| CD
for  ||| S:1314 E:1318 ||| IN
their  ||| S:1318 E:1324 ||| PRP$
clients ||| S:1324 E:1331 ||| NNS
,  ||| S:1331 E:1333 ||| ,
one  ||| S:1333 E:1337 ||| CD
for  ||| S:1337 E:1341 ||| IN
both ||| S:1341 E:1345 ||| DT
,  ||| S:1345 E:1347 ||| ,
six  ||| S:1347 E:1351 ||| CD
for  ||| S:1351 E:1355 ||| IN
MSM  ||| S:1355 E:1359 ||| NNP
and  ||| S:1359 E:1363 ||| CC
one  ||| S:1363 E:1367 ||| CD
for  ||| S:1367 E:1371 ||| IN
PWID ||| S:1371 E:1375 ||| NNP
.  ||| S:1375 E:1377 ||| .
The  ||| S:1377 E:1381 ||| DT
pooled  ||| S:1381 E:1388 ||| JJ
HIV  ||| S:1388 E:1392 ||| NNP
prevalence  ||| S:1392 E:1403 ||| NN
among  ||| S:1403 E:1409 ||| IN
FSWs  ||| S:1409 E:1414 ||| NNP
was  ||| S:1414 E:1418 ||| VBD
34.9 ||| S:1418 E:1422 ||| CD
%  ||| S:1422 E:1424 ||| NN
( ||| S:1424 E:1425 ||| -LRB-
n=14,388 ||| S:1425 E:1433 ||| CD
/ ||| S:1433 E:1434 ||| CD
41,270 ||| S:1434 E:1440 ||| CD
) ||| S:1440 E:1441 ||| -RRB-
,  ||| S:1441 E:1443 ||| ,
among  ||| S:1443 E:1449 ||| IN
their  ||| S:1449 E:1455 ||| PRP$
clients  ||| S:1455 E:1463 ||| NNS
was  ||| S:1463 E:1467 ||| VBD
7.3 ||| S:1467 E:1470 ||| CD
%  ||| S:1470 E:1472 ||| NN
( ||| S:1472 E:1473 ||| -LRB-
n=435 ||| S:1473 E:1478 ||| CD
/ ||| S:1478 E:1479 ||| CD
5986 ||| S:1479 E:1483 ||| CD
) ||| S:1483 E:1484 ||| -RRB-
,  ||| S:1484 E:1486 ||| ,
among  ||| S:1486 E:1492 ||| IN
MSM  ||| S:1492 E:1496 ||| NNP
was  ||| S:1496 E:1500 ||| VBD
17.7 ||| S:1500 E:1504 ||| CD
%  ||| S:1504 E:1506 ||| NN
( ||| S:1506 E:1507 ||| -LRB-
n=656 ||| S:1507 E:1512 ||| CD
/ ||| S:1512 E:1513 ||| CD
3714 ||| S:1513 E:1517 ||| CD
)  ||| S:1517 E:1519 ||| -RRB-
and  ||| S:1519 E:1523 ||| CC
among  ||| S:1523 E:1529 ||| IN
PWID  ||| S:1529 E:1534 ||| NNP
from  ||| S:1534 E:1539 ||| IN
one  ||| S:1539 E:1543 ||| CD
study  ||| S:1543 E:1549 ||| NN
in  ||| S:1549 E:1552 ||| IN
Nigeria  ||| S:1552 E:1560 ||| NNP
was  ||| S:1560 E:1564 ||| VBD
3.8 ||| S:1564 E:1567 ||| CD
%  ||| S:1567 E:1569 ||| NN
( ||| S:1569 E:1570 ||| -LRB-
n=56 ||| S:1570 E:1574 ||| CD
/ ||| S:1574 E:1575 ||| CD
1459 ||| S:1575 E:1579 ||| CD
) ||| S:1579 E:1580 ||| -RRB-
.  ||| S:1580 E:1582 ||| .
The  ||| S:1582 E:1586 ||| DT
disproportionate  ||| S:1586 E:1603 ||| JJ
burden  ||| S:1603 E:1610 ||| NN
of  ||| S:1610 E:1613 ||| IN
HIV  ||| S:1613 E:1617 ||| NNP
among  ||| S:1617 E:1623 ||| IN
FSWs  ||| S:1623 E:1628 ||| NNP
appears  ||| S:1628 E:1636 ||| VBZ
to  ||| S:1636 E:1639 ||| TO
be  ||| S:1639 E:1642 ||| VB
consistent  ||| S:1642 E:1653 ||| JJ
from  ||| S:1653 E:1658 ||| IN
the  ||| S:1658 E:1662 ||| DT
beginning  ||| S:1662 E:1672 ||| NN
of  ||| S:1672 E:1675 ||| IN
the  ||| S:1675 E:1679 ||| DT
HIV  ||| S:1679 E:1683 ||| NNP
epidemic  ||| S:1683 E:1692 ||| NN
in  ||| S:1692 E:1695 ||| IN
WCA ||| S:1695 E:1698 ||| NNP
.  ||| S:1698 E:1700 ||| .
While  ||| S:1700 E:1706 ||| IN
there  ||| S:1706 E:1712 ||| EX
are  ||| S:1712 E:1716 ||| VBP
less  ||| S:1716 E:1721 ||| JJR
data  ||| S:1721 E:1726 ||| NNS
for  ||| S:1726 E:1730 ||| IN
other  ||| S:1730 E:1736 ||| JJ
key  ||| S:1736 E:1740 ||| JJ
populations  ||| S:1740 E:1752 ||| NNS
such  ||| S:1752 E:1757 ||| JJ
as  ||| S:1757 E:1760 ||| IN
clients  ||| S:1760 E:1768 ||| NNS
of  ||| S:1768 E:1771 ||| IN
FSWs  ||| S:1771 E:1776 ||| JJ
and  ||| S:1776 E:1780 ||| CC
MSM ||| S:1780 E:1783 ||| NNP
,  ||| S:1783 E:1785 ||| ,
the  ||| S:1785 E:1789 ||| DT
prevalence  ||| S:1789 E:1800 ||| NN
of  ||| S:1800 E:1803 ||| IN
HIV  ||| S:1803 E:1807 ||| NNP
is  ||| S:1807 E:1810 ||| VBZ
higher  ||| S:1810 E:1817 ||| JJR
among  ||| S:1817 E:1823 ||| IN
these  ||| S:1823 E:1829 ||| DT
men  ||| S:1829 E:1833 ||| NNS
compared  ||| S:1833 E:1842 ||| VBN
to  ||| S:1842 E:1845 ||| TO
other  ||| S:1845 E:1851 ||| JJ
men  ||| S:1851 E:1855 ||| NNS
in  ||| S:1855 E:1858 ||| IN
the  ||| S:1858 E:1862 ||| DT
region ||| S:1862 E:1868 ||| NN
.  ||| S:1868 E:1870 ||| .
There  ||| S:1870 E:1876 ||| EX
have  ||| S:1876 E:1881 ||| VBP
been  ||| S:1881 E:1886 ||| VBN
sporadic  ||| S:1886 E:1895 ||| JJ
reports  ||| S:1895 E:1903 ||| NNS
among  ||| S:1903 E:1909 ||| IN
PWID ||| S:1909 E:1913 ||| NNP
,  ||| S:1913 E:1915 ||| ,
but  ||| S:1915 E:1919 ||| CC
limited  ||| S:1919 E:1927 ||| JJ
research  ||| S:1927 E:1936 ||| NN
on  ||| S:1936 E:1939 ||| IN
the  ||| S:1939 E:1943 ||| DT
burden  ||| S:1943 E:1950 ||| NN
of  ||| S:1950 E:1953 ||| IN
HIV  ||| S:1953 E:1957 ||| NNP
among  ||| S:1957 E:1963 ||| IN
these  ||| S:1963 E:1969 ||| DT
men  ||| S:1969 E:1973 ||| NNS
and  ||| S:1973 E:1977 ||| CC
women ||| S:1977 E:1982 ||| NNS
.  ||| S:1982 E:1984 ||| .
These  ||| S:1984 E:1990 ||| DT
data  ||| S:1990 E:1995 ||| NN
affirm  ||| S:1995 E:2002 ||| NN
that  ||| S:2002 E:2007 ||| IN
the  ||| S:2007 E:2011 ||| DT
HIV  ||| S:2011 E:2015 ||| NNP
epidemic  ||| S:2015 E:2024 ||| NN
in  ||| S:2024 E:2027 ||| IN
WCA  ||| S:2027 E:2031 ||| NNP
appears  ||| S:2031 E:2039 ||| VBZ
to  ||| S:2039 E:2042 ||| TO
be  ||| S:2042 E:2045 ||| VB
far  ||| S:2045 E:2049 ||| RB
more  ||| S:2049 E:2054 ||| RBR
concentrated  ||| S:2054 E:2067 ||| VBN
among  ||| S:2067 E:2073 ||| IN
key  ||| S:2073 E:2077 ||| JJ
populations  ||| S:2077 E:2089 ||| NNS
than  ||| S:2089 E:2094 ||| IN
the  ||| S:2094 E:2098 ||| DT
epidemics  ||| S:2098 E:2108 ||| NN
in  ||| S:2108 E:2111 ||| IN
Southern  ||| S:2111 E:2120 ||| NNP
and  ||| S:2120 E:2124 ||| CC
Eastern  ||| S:2124 E:2132 ||| NNP
Africa ||| S:2132 E:2138 ||| NNP
.  ||| S:2138 E:2140 ||| .
Evidence-based  ||| S:2140 E:2155 ||| NNP
HIV  ||| S:2155 E:2159 ||| NNP
prevention ||| S:2159 E:2169 ||| NN
,  ||| S:2169 E:2171 ||| ,
treatment  ||| S:2171 E:2181 ||| NN
and  ||| S:2181 E:2185 ||| CC
care  ||| S:2185 E:2190 ||| NN
programmes  ||| S:2190 E:2201 ||| NN
in  ||| S:2201 E:2204 ||| IN
WCA  ||| S:2204 E:2208 ||| NNP
should  ||| S:2208 E:2215 ||| MD
focus  ||| S:2215 E:2221 ||| VB
on  ||| S:2221 E:2224 ||| IN
engaging  ||| S:2224 E:2233 ||| JJ
populations  ||| S:2233 E:2245 ||| NNS
with  ||| S:2245 E:2250 ||| IN
the  ||| S:2250 E:2254 ||| DT
greatest  ||| S:2254 E:2263 ||| JJS
burden  ||| S:2263 E:2270 ||| NN
of  ||| S:2270 E:2273 ||| IN
disease  ||| S:2273 E:2281 ||| NN
in  ||| S:2281 E:2284 ||| IN
the  ||| S:2284 E:2288 ||| DT
continuum  ||| S:2288 E:2298 ||| NN
of  ||| S:2298 E:2301 ||| IN
HIV  ||| S:2301 E:2305 ||| NNP
care ||| S:2305 E:2309 ||| NN
.  ||| S:2309 E:2311 ||| .
